Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.68 |
| ▸ | HPGD | P15428 | 5/20 | 0.68 |
| ▸ | TSHR | P16473 | 3/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | KCNA3 | P22001 | 6/20 | 0.66 |
| ▸ | KCNA2 | P16389 | 1/20 | 0.66 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | MAOA | P21397 | 3/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.58 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6995876 | 0.82 | ALDH1A1 (0.78) | ALDH1A1KDM4EHSD17B10HPGDTSHR | |
| SCHEMBL19248241 | 0.82 | ALDH1A1 (0.67) | ALDH1A1KDM4EHSD17B10HPGDTSHR | |
| SCHEMBL11380969 | 0.81 | ALDH1A1 (1.00) | ALDH1A1KDM4EHSD17B10HPGDTSHR | |
| Hydrochloric Acid SCHEMBL7000338 | 0.81 | ALDH1A1 (0.76) | ALDH1A1KDM4EHSD17B10HPGDTSHR | |
| SCHEMBL18074127 | 0.80 | KCNA3 (0.79) | ALDH1A1KDM4EHSD17B10HPGDTSHR | |
| SCHEMBL18074006 | 0.80 | KCNA3 (1.00) | ALDH1A1KDM4EHSD17B10HPGDTSHR | |
| SCHEMBL11376434 | 0.80 | ALDH1A1 (0.68) | ALDH1A1KDM4EHSD17B10HPGDTSHR | |
| SCHEMBL18788580 | 0.78 | KCNA3 (0.67) | ALDH1A1KDM4EHSD17B10HPGDTSHR | |
| 4,6,7-Trimethyl-2H-Chromen-2-One SCHEMBL19049403 | 0.78 | KDM4E (0.68) | ALDH1A1KDM4EHSD17B10HPGDTSHR | |
| SCHEMBL9120159 | 0.77 | ALDH1A1 (0.63) | ALDH1A1KDM4EHSD17B10HPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0579784-B1 | METHOD FOR PREVENTING RESTENOSIS FOLLOWING RECONFIGURATION OF BODY VESSELS | ADVANCED RES & TECH INST (US) | 1999-11-10 | — | — | EP | claimed |
| EP-0579784-A4 | — | — | 1994-04-06 | — | — | EP | claimed |
| EP-0579784-A1 | METHOD FOR PREVENTING RESTENOSIS FOLLOWING RECONFIGURATION OF BODY VESSELS | INDIANA UNIVERSITY FOUNDATION (US) | 1994-01-26 | — | — | EP | claimed |
| WO-1992018122-A1 | METHOD FOR PREVENTING RESTENOSIS FOLLOWING RECONFIGURATION OF BODY VESSELS | INDIANA UNIVERSITY FOUNDATION (US) | 1992-10-29 | — | — | WO | claimed |
| US-5116864-A | Method for preventing restenosis following reconfiguration of body vessels | INDIANA UNIVERSITY FOUNDATION (US) | 1992-05-26 | — | — | US | claimed |
| US-4950770-A | Psoralens aminomethylation | ELDER PHARMACEUTICALS, INC. (US) | 1990-08-21 | — | — | US | claimed |
| US-4748120-A | Photochemical decontamination treatment of whole blood or blood components | DIAMOND SCIENTIFIC CO. (US) | 1988-05-31 | — | — | US | claimed |
| WO-2023164075-A1 | THERMOSTABLE UV INACTIVATED VACCINES AND OTHER BIOPHARMACEUTICALS | UNIVERSAL STABILIZATION TECHNOLOGIES INC. (US) | 2023-08-31 | — | — | WO | disclosed |
| US-20220168411-A1 | PSORALEN-INACTIVATED CORONAVIRUS VACCINE AND METHOD OF PREPARATION | THE UNITED STATES OF AMERICAN AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2022-06-02 | — | — | US | disclosed |
| US-20180169433-A1 | METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS WITH PSORALEN DERIVATIVES | IMMUNOLIGHT, LLC (US) | 2018-06-21 | — | — | US | disclosed |
| US-20180169433-A1 | METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS WITH PSORALEN DERIVATIVES | IMMUNOLIGHT, LLC (US) | 2018-06-21 | — | — | US | disclosed |
| US-20170113061-A1 | METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS WITH PSORALEN DERIVATIVES | IMMUNOLIGHT, LLC (US) | 2017-04-27 | — | — | US | disclosed |
| US-20150291936-A1 | PSORALEN-INACTIVATED DENGUE VIRUS VACCINE AND METHOD OF PREPARATION | THE UNITED STATES OF AMERICAN AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2015-10-15 | — | — | US | disclosed |
| US-4727027-A | FUROCOUMARIN DERIVATIVE AND ULTRAVIOLET IRRADIATION | DIAMOND SCIENTIFIC CO. (US) | 1988-02-23 | — | — | US | disclosed |
| US-4693981-A | ULTRAVIOLET RADIATION AND FUROCOUMARIN | ADVANCED GENETICS RESEARCH INSTITUTE (US) | 1987-09-15 | — | — | US | disclosed |
| US-4556556-A | ULTRAVIOLET INACTIVATION IN THE PRESENCE OF A FUROCOUMARIN COMPOUND | ADVANCED GENETICS RESEARCH INSTITUTE (US) | 1985-12-03 | — | — | US | disclosed |
| US-4545987-A | Psoralen inactivated double-stranded RNA viral vaccines | ADVANCED GENETICS RESEARCH INSTITUTE (US) | 1985-10-08 | — | — | US | disclosed |
| EP-0124363-A2 | Photochemical decontamination treatment of whole blood or blood components | DIAMOND SCIENTIFIC CO. (US) | 1984-11-07 | — | — | EP | disclosed |
| US-4298614-A | 5'-Aminoalkyl-4',4-dialkylpsoralens | THOMAS C. ELDER, INC. (US) | 1981-11-03 | — | — | US | disclosed |
| US-4279922-A | Photosensitizing benzofuranacrylics | THOMAS C. ELDER, INC. (US) | 1981-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170113061-A1 | METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS WITH PSORALEN DERIVATIVES | NFATC1, CDK10, CDK20 | ALDH1A1 1790/4885KDM4E 655/4885HSD17B10 259/4885 |
| US-20180169433-A1 | METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS WITH PSORALEN DERIVATIVES | NFATC1, CDK10, PDCD10 | ALDH1A1 1556/4885KDM4E 948/4885HSD17B10 387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.